Retractable Technologies Inc (RVP): R&D Expense
$675.6K
Year ended 2025-12-31
$682.0K
Trailing 12 months to 2026-06-30
+8.7%
3-year compound annual growth
+3.3%
5-year compound annual growth
+1.1%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $675.6K | +0.2% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $673.9K | +16.0% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $581.2K | +10.5% | 2026-03-27, From 2023-01-01 |
| 2022-12-31 | $525.7K | -41.7% | 2025-03-28, From 2022-01-01 |
| 2021-12-31 | $901.4K | +56.9% | 2024-03-29, From 2021-01-01 |
| 2020-12-31 | $574.5K | +11.3% | 2023-03-30, From 2020-01-01 |
| 2019-12-31 | $516.1K | -16.9% | 2022-03-31, From 2019-01-01 |
| 2018-12-31 | $621.4K | -16.1% | 2021-03-31, From 2018-01-01 |
| 2017-12-31 | $740.6K | +29.5% | 2020-03-30, From 2017-01-01 |
| 2016-12-31 | $571.8K | -5.9% | 2019-03-28, From 2016-01-01 |
| 2015-12-31 | $607.5K | -1.5% | 2018-04-02, From 2015-01-01 |
| 2014-12-31 | $616.8K | -26.3% | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | $837.1K | -4.0% | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | $871.9K | +7.0% | 2015-03-31, From 2012-01-01 |
| 2011-12-31 | $815.0K | -8.0% | 2014-03-31, From 2011-01-01 |
| 2010-12-31 | $885.4K | -14.1% | 2013-04-01, From 2010-01-01 |
| 2009-12-31 | $1.03M | n/a | 2012-03-30, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Retractable Technologies Inc (RVP) | 2025-12-31 | $675.6K | +0.2% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $668.0K | -17.8% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $642.0K | -5.0% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $13.90M | +12.1% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $3.69M | +47.9% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $58.19M | +35.9% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $1.35M | +101.0% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $14.96M | -15.4% |
Compare RVP, UTMD, IDXG, CLPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗